Alpha-synuclein-modulating compositions and methods of use thereof
TW202639852APending Publication Date: 2026-10-01ADARX PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114148743
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-11
- Filing Date
- 2025-12-11
- Publication Date
- 2026-10-01
Smart Images
Figure TWG2TA001078778_001 
Figure TWG2TA001078778_002 
Figure TWG2TA001078778_003
Abstract
Aspects of the disclosure provide compounds, compositions, and methods for modulating the expression, translation, and / or activity of alpha-synuclein (aSyn). In some aspects, the compounds, compositions, and methods of the disclosure can be used to reduce the expression of SNCA mRNA in a cell or animal. In some aspects, the compounds, compositions, and methods of the disclosure can be used to reduce the expression of aSyn in a cell or animal.
Need to check novelty before this filing date? Find Prior Art